Published in Psychol Addict Behav on May 28, 2012
A smartphone application to support recovery from alcoholism: a randomized clinical trial. JAMA Psychiatry (2014) 3.71
The interacting effect of depressive symptoms, gender, and distress tolerance on substance use problems among residential treatment-seeking substance users. Drug Alcohol Depend (2015) 0.82
Alcohol Use Predicts Number of Sexual Partners for Female but not Male STI Clinic Patients. AIDS Behav (2016) 0.81
Recommendations for the Design and Analysis of Treatment Trials for Alcohol Use Disorders. Alcohol Clin Exp Res (2015) 0.80
Is the quality of brief motivational interventions for drug use in primary care associated with subsequent drug use? Addict Behav (2016) 0.77
Measurement Invariance of the Short Inventory of Problems-Revised Across African American and Non-Latino White Substance Users. J Ethn Cult Divers Soc Work (2015) 0.75
The intervening role of urgency on the association between childhood maltreatment, PTSD, and substance-related problems. Addict Behav (2017) 0.75
Psychometric properties of a Spanish-language version of the Short Inventory of Problems. Psychol Addict Behav (2013) 0.75
Internalized stigma as an independent risk factor for substance use problems among primary care patients: Rationale and preliminary support. Drug Alcohol Depend (2017) 0.75
The timeline followback reports of psychoactive substance use by drug-abusing patients: psychometric properties. J Consult Clin Psychol (2000) 7.71
Substance abuse treatment entry, retention, and outcome in women: a review of the literature. Drug Alcohol Depend (2006) 5.64
Motivational interviewing to improve treatment engagement and outcome in individuals seeking treatment for substance abuse: a multisite effectiveness study. Drug Alcohol Depend (2005) 4.65
A new measure of substance abuse treatment. Initial studies of the treatment services review. J Nerv Ment Dis (1992) 4.64
Opioid-, cannabis- and alcohol-dependent women show more rapid progression to substance abuse treatment. Drug Alcohol Depend (2004) 3.09
The reliability and validity of a scale to measure HIV risk-taking behaviour among intravenous drug users. AIDS (1991) 3.05
Site matters: multisite randomized trial of motivational enhancement therapy in community drug abuse clinics. J Consult Clin Psychol (2007) 2.98
Characteristics, beliefs, and practices of community clinicians trained to provide manual-guided therapy for substance abusers. J Subst Abuse Treat (2002) 2.70
Stages of change profiles in outpatient alcoholism treatment. J Subst Abuse (1990) 2.69
The inventory of drug use consequences (InDUC): test-retest stability and sensitivity to detect change. Psychol Addict Behav (2002) 2.08
MET meets the real world: design issues and clinical strategies in the Clinical Trials Network. J Subst Abuse Treat (2002) 2.08
Factor and item-response analysis DSM-IV criteria for abuse of and dependence on cannabis, cocaine, hallucinogens, sedatives, stimulants and opioids. Addiction (2007) 1.96
The role of functional social support in treatment retention and outcomes among outpatient adult substance abusers. Addiction (2002) 1.93
Assessing consequences of substance use: psychometric properties of the inventory of drug use consequences. Psychol Addict Behav (2003) 1.87
Psychometric properties of the short index of problems as a measure of recent alcohol-related problems. Alcohol Clin Exp Res (2003) 1.84
Substance Dependence Severity Scale (SDSS): reliability and validity of a clinician-administered interview for DSM-IV substance use disorders. Drug Alcohol Depend (2000) 1.54
Reliability and validity of the alcohol short index of problems and a newly constructed drug short index of problems. J Stud Alcohol Drugs (2009) 1.45
Motivational subtypes and continuous measures of readiness for change: concurrent and predictive validity. Psychol Addict Behav (2003) 1.43
Entering treatment for alcohol abuse: a stress and coping model. Addiction (1995) 1.40
Assessing negative consequences in patients with substance use and bipolar disorders: psychometric properties of the short inventory of problems (SIP). Am J Addict (2007) 1.33
Concurrent and predictive validity of the Substance Dependence Severity Scale (SDSS). Drug Alcohol Depend (2000) 1.26
Retention predictors related to intensive outpatient programs for substance use disorders. Am J Drug Alcohol Abuse (2000) 1.15
Measuring outcome in interventions for alcohol dependence and problem drinking: executive summary of a conference sponsored by the national institute on alcohol abuse and alcoholism. Alcohol Clin Exp Res (2003) 1.13
Can the short index of problems (SIP) be improved? Validity and reliability of the three-month SIP in an emergency department sample. J Stud Alcohol (2005) 1.12
Retention in psychosocial treatment of cocaine dependence: predictors and impact on outcome. Am J Addict (2002) 1.12
Client-related predictors of early treatment drop-out in a substance abuse clinic exclusively employing individual therapy. J Subst Abuse Treat (2004) 1.07
Predictors of attrition from a national sample of methadone maintenance patients. Am J Drug Alcohol Abuse (2010) 1.07
Gender differences in problem severity at assessment and treatment retention. J Subst Abuse Treat (2001) 1.05
An Item Response Theory (IRT) analysis of the Short Inventory of Problems-Alcohol and Drugs (SIP-AD) among non-treatment seeking men-who-have-sex-with-men: evidence for a shortened 10-item SIP-AD. Addict Behav (2009) 1.02
Recent drinking consequences, motivation to change, and changes in alcohol consumption over a three month period. Addict Behav (2005) 0.98
Assessing nondrinking outcomes in combined pharmacotherapy and psychotherapy clinical trials for the treatment of alcohol dependence. J Stud Alcohol Suppl (2005) 0.95
Predicting treatment retention among cocaine users. Int J Addict (1993) 0.93
Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study: a randomized controlled trial. JAMA (2006) 13.15
We don't train in vain: a dissemination trial of three strategies of training clinicians in cognitive-behavioral therapy. J Consult Clin Psychol (2005) 4.71
Motivational interviewing to improve treatment engagement and outcome in individuals seeking treatment for substance abuse: a multisite effectiveness study. Drug Alcohol Depend (2005) 4.65
Behavioral impulsivity predicts treatment outcome in a smoking cessation program for adolescent smokers. Drug Alcohol Depend (2006) 3.61
Primary outcome indices in illicit drug dependence treatment research: systematic approach to selection and measurement of drug use end-points in clinical trials. Addiction (2011) 3.42
Single versus multiple drug focus in substance abuse clinical trials research. Drug Alcohol Depend (2003) 3.19
Medical morbidity, mental illness, and substance use disorders. Psychiatr Serv (2002) 3.15
Prize reinforcement contingency management for treating cocaine users: how low can we go, and with whom? Addiction (2004) 3.06
Site matters: multisite randomized trial of motivational enhancement therapy in community drug abuse clinics. J Consult Clin Psychol (2007) 2.98
Impact of substance use disorders on recovery from episodes of depression in bipolar disorder patients: prospective data from the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD). Am J Psychiatry (2009) 2.39
Community program therapist adherence and competence in motivational enhancement therapy. Drug Alcohol Depend (2008) 2.33
Acceptability of drug testing in an outpatient substance abuse program for adolescents. J Adolesc Health (2010) 2.12
MET meets the real world: design issues and clinical strategies in the Clinical Trials Network. J Subst Abuse Treat (2002) 2.08
Development of a robust and repeatable UPLC-MS method for the long-term metabolomic study of human serum. Anal Chem (2009) 2.06
Pretreatment brain activation during stroop task is associated with outcomes in cocaine-dependent patients. Biol Psychiatry (2008) 2.04
Contingency management treatments: Reinforcing abstinence versus adherence with goal-related activities. J Consult Clin Psychol (2006) 1.98
Interactive effect of stressful life events and the serotonin transporter 5-HTTLPR genotype on posttraumatic stress disorder diagnosis in 2 independent populations. Arch Gen Psychiatry (2009) 1.97
Computer-assisted delivery of cognitive-behavioral therapy: efficacy and durability of CBT4CBT among cocaine-dependent individuals maintained on methadone. Am J Psychiatry (2014) 1.93
The relationship between smoking and suicidal behavior, comorbidity, and course of illness in bipolar disorder. J Clin Psychiatry (2006) 1.93
Clinical correlates of co-occurring cannabis and tobacco use: a systematic review. Addiction (2012) 1.93
Classification and definition of misuse, abuse, and related events in clinical trials: ACTTION systematic review and recommendations. Pain (2013) 1.89
Assessing consequences of substance use: psychometric properties of the inventory of drug use consequences. Psychol Addict Behav (2003) 1.87
Methadone versus buprenorphine with contingency management or performance feedback for cocaine and opioid dependence. Am J Psychiatry (2005) 1.82
Impact of attention-deficit/hyperactivity disorder (ADHD) treatment on smoking cessation intervention in ADHD smokers: a randomized, double-blind, placebo-controlled trial. J Clin Psychiatry (2010) 1.81
Alcohol and sexual HIV risk behavior among problem drinking men who have sex with men: An event level analysis of timeline followback data. AIDS Behav (2006) 1.80
Mindfulness training for smoking cessation: results from a randomized controlled trial. Drug Alcohol Depend (2011) 1.68
Effects of prototypical microsomal enzyme inducers on cytochrome P450 expression in cultured human hepatocytes. Drug Metab Dispos (2003) 1.66
Mindfulness training and stress reactivity in substance abuse: results from a randomized, controlled stage I pilot study. Subst Abus (2009) 1.62
Self-help organizations for alcohol and drug problems: toward evidence-based practice and policy. J Subst Abuse Treat (2004) 1.59
Neuroscience of behavioral and pharmacological treatments for addictions. Neuron (2011) 1.57
Cognitive enhancement as a treatment for drug addictions. Neuropharmacology (2012) 1.54
Physical pain and associated clinical characteristics in treatment-seeking patients in four substance use disorder treatment modalities. Am J Addict (2008) 1.52
Active ingredients: how and why evidence-based alcohol behavioral treatment interventions work. Alcohol Clin Exp Res (2005) 1.51
Initial response as a predictor of 12-week buprenorphine-naloxone treatment response in a prescription opioid-dependent population. J Clin Psychiatry (2015) 1.51
An initial study of neural responses to monetary incentives as related to treatment outcome in cocaine dependence. Biol Psychiatry (2011) 1.50
The effects of gender, age, ethnicity, and liver cirrhosis on cytochrome P450 enzyme activity in human liver microsomes and inducibility in cultured human hepatocytes. Toxicol Appl Pharmacol (2004) 1.50
Correspondence of motivational enhancement treatment integrity ratings among therapists, supervisors, and observers. Psychother Res (2009) 1.49
A structured approach to medical management: a psychosocial intervention to support pharmacotherapy in the treatment of alcohol dependence. J Stud Alcohol Suppl (2005) 1.47
Intention-to-treat meets missing data: implications of alternate strategies for analyzing clinical trials data. Drug Alcohol Depend (2002) 1.45
What is usual about "treatment-as-usual"? Data from two multisite effectiveness trials. J Subst Abuse Treat (2008) 1.45
Motivational subtypes and continuous measures of readiness for change: concurrent and predictive validity. Psychol Addict Behav (2003) 1.43
Seeking safety therapy for adolescent girls with PTSD and substance use disorder: a randomized controlled trial. J Behav Health Serv Res (2006) 1.39
Design and methodological considerations of an effectiveness trial of a computer-assisted intervention: an example from the NIDA Clinical Trials Network. Contemp Clin Trials (2011) 1.38
Assessing the role of Asp 194 in the transmembrane domains of the α-chain of the high-affinity receptor complex for immunoglobulin E in signal transduction. Mol Immunol (2010) 1.38
Reasons for dropout from drug abuse treatment: symptoms, personality, and motivation. Addict Behav (2005) 1.36
Patient characteristics associated with buprenorphine/naloxone treatment outcome for prescription opioid dependence: Results from a multisite study. Drug Alcohol Depend (2013) 1.33
A cognitive behavioral therapy for alcohol-dependent domestic violence offenders: an integrated substance abuse-domestic violence treatment approach (SADV). Am J Addict (2007) 1.33
Making consent more informed: preliminary results from a multiple-choice test among probation-referred marijuana users entering a randomized clinical trial. J Am Acad Psychiatry Law (2008) 1.33
Assessing negative consequences in patients with substance use and bipolar disorders: psychometric properties of the short inventory of problems (SIP). Am J Addict (2007) 1.33
Quality versus quantity: acquisition of coping skills following computerized cognitive-behavioral therapy for substance use disorders. Addiction (2010) 1.32
A randomized trial adapting contingency management targets based on initial abstinence status of cocaine-dependent patients. J Consult Clin Psychol (2012) 1.32
Substance use histories in patients seeking treatment for controlled-release oxycodone dependence. Drug Alcohol Depend (2004) 1.30
Improving the care of individuals with schizophrenia and substance use disorders: consensus recommendations. J Psychiatr Pract (2005) 1.30
Treatment outcomes of a stage 1 cognitive-behavioral trial to reduce alcohol use among human immunodeficiency virus-infected out-patients in western Kenya. Addiction (2011) 1.29
One small step for manuals: Computer-assisted training in twelve-step facilitation. J Stud Alcohol (2006) 1.29
The cost-effectiveness of four treatments for marijuana dependence. Addiction (2007) 1.29
The validity of cocaine dependence subtypes. Addict Behav (2007) 1.28
D-Cycloserine attenuates reactivity to smoking cues in nicotine dependent smokers: a pilot investigation. Drug Alcohol Depend (2009) 1.27
Adverse childhood events as risk factors for substance dependence: partial mediation by mood and anxiety disorders. Addict Behav (2009) 1.27
Does report of craving opioid medication predict aberrant drug behavior among chronic pain patients? Clin J Pain (2009) 1.27
Engaging young probation-referred marijuana-abusing individuals in treatment: a pilot trial. Am J Addict (2003) 1.27
A methodological analysis of randomized clinical trials of computer-assisted therapies for psychiatric disorders: toward improved standards for an emerging field. Am J Psychiatry (2011) 1.26
Accounting for the social triggers of sexual compulsivity. J Addict Dis (2007) 1.24
Health-related quality of life for adults participating in outpatient substance abuse treatment. Am J Addict (2003) 1.24
Seeking Safety plus Exposure Therapy: an outcome study on dual diagnosis men. J Psychoactive Drugs (2005) 1.24
Explanations for the origins of sexual compulsivity among gay and bisexual men. Arch Sex Behav (2007) 1.24
HIV risk behavior among patients with co-occurring bipolar and substance use disorders: associations with mania and drug abuse. Drug Alcohol Depend (2007) 1.23
Recruiting hard-to-reach drug-using men who have sex with men into an intervention study: lessons learned and implications for applied research. Subst Use Misuse (2009) 1.21
Serious adverse events in randomized psychosocial treatment studies: safety or arbitrary edicts? J Consult Clin Psychol (2008) 1.20
Evaluating motivational enhancement therapy adherence and competence among Spanish-speaking therapists. Drug Alcohol Depend (2009) 1.20
Combining cognitive behavioral therapy with contingency management for smoking cessation in adolescent smokers: a preliminary comparison of two different CBT formats. Am J Addict (2007) 1.20
Teaching community program clinicians motivational interviewing using expert and train-the-trainer strategies. Addiction (2010) 1.20
Clinical factors associated with prescription drug use disorder in urban primary care patients with chronic pain. J Pain (2010) 1.19
A preliminary study of the neural effects of behavioral therapy for substance use disorders. Drug Alcohol Depend (2011) 1.18
Client satisfaction with three therapies in the treatment of alcohol dependence: results from project MATCH. Am J Addict (2002) 1.16
The alliance in motivational enhancement therapy and counseling as usual for substance use problems. J Consult Clin Psychol (2009) 1.16
Drug-use patterns among men who have sex with men presenting for alcohol treatment: differences in ethnic and sexual identity. J Urban Health (2005) 1.14
Treatment of patients with substance use disorders, second edition. American Psychiatric Association. Am J Psychiatry (2007) 1.14
Treatment process, alliance and outcome in brief versus extended treatments for marijuana dependence. Addiction (2010) 1.12
The URICA as a measure of motivation to change among treatment-seeking individuals with concurrent alcohol and cocaine problems. Psychol Addict Behav (2002) 1.12
Tailoring cannabis dependence treatment for a diverse population. Addiction (2002) 1.12
Past anabolic-androgenic steroid use among men admitted for substance abuse treatment: an underrecognized problem? J Clin Psychiatry (2003) 1.11
Understanding messaging preferences to inform development of mobile goal-directed behavioral interventions. J Med Internet Res (2014) 1.11
A randomized controlled pilot study of motivational interviewing for patients with psychotic and drug use disorders. Addiction (2006) 1.11
Contingency Management to reduce substance use in individuals who are homeless with co-occurring psychiatric disorders. Am J Drug Alcohol Abuse (2007) 1.10
Cost-effectiveness of computer-assisted training in cognitive-behavioral therapy as an adjunct to standard care for addiction. Drug Alcohol Depend (2010) 1.10
Effect of anxiety on treatment presentation and outcome: results from the Marijuana Treatment Project. Psychiatry Res (2010) 1.10
Systematic cultural adaptation of cognitive-behavioral therapy to reduce alcohol use among HIV-infected outpatients in western Kenya. AIDS Behav (2010) 1.10
Ethnic differences in substance abuse treatment retention, compliance, and outcome from two clinical trials. Psychiatr Serv (2004) 1.10
Issues in designing and implementing a Spanish-language multi-site clinical trial. Am J Addict (2007) 1.09
Gender differences in a clinical trial for prescription opioid dependence. J Subst Abuse Treat (2013) 1.08
Randomized, double blind, placebo-controlled trial of disulfiram for the treatment of cocaine dependence in methadone-stabilized patients. Drug Alcohol Depend (2010) 1.08
Mutual influence in therapist competence and adherence to motivational enhancement therapy. Drug Alcohol Depend (2011) 1.08
Addressing substance abuse in health care settings. Alcohol Clin Exp Res (2006) 1.08
Functional brain networks associated with cognitive control, cocaine dependence, and treatment outcome. Psychol Addict Behav (2012) 1.08
White matter integrity is associated with treatment outcome measures in cocaine dependence. Neuropsychopharmacology (2010) 1.07
A cognitive behavioral therapy for co-occurring substance use and posttraumatic stress disorders. Addict Behav (2009) 1.07
Domestic violence in women with PTSD and substance abuse. Addict Behav (2004) 1.07
Correlates of co-occurring ADHD in drug-dependent subjects: prevalence and features of substance dependence and psychiatric disorders. Addict Behav (2008) 1.06